Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abatacept in Active Psoriatic Arthritis
NCT01860976Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Jun 2013
- Primary completion
- Jul 2015
- Modality
- Fc-Fusion Proteins
- Countries
- 17
01
Overview
A Phase 3 trial of abatacept in psoriatic arthritis (PsA), sponsored by Bristol Myers Squibb. Started Jun 2013; status: completed.
02
Drugs
abatacept
03
Conditions
psoriatic arthritis (PsA)
Beyond the preview
Go deeper on NCT01860976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01860976.